LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 328 of 535
Next
>>
>
8176 to 8200 of 13356 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	GSK1904529A	0.12	uM	LJP6	1	H23	72	hr	1097	3259	3610	0.9026	0.8843
BT-20	GSK1904529A	0.12	uM	LJP6	2	H23	72	hr	1097	3461	3713	0.9320	0.9215
BT-20	GSK1904529A	0.12	uM	LJP6	3	H23	72	hr	1097	3147	3696	0.8514	0.8245
BT-20	GSK1904529A	0.37	uM	LJP6	1	H22	72	hr	1097	3260	3610	0.9029	0.8846
BT-20	GSK1904529A	0.37	uM	LJP6	2	H22	72	hr	1097	3439	3713	0.9260	0.9145
BT-20	GSK1904529A	0.37	uM	LJP6	3	H22	72	hr	1097	3358	3696	0.9084	0.8934
BT-20	GSK1904529A	1.11	uM	LJP6	1	H21	72	hr	1097	3193	3610	0.8844	0.8619
BT-20	GSK1904529A	1.11	uM	LJP6	2	H21	72	hr	1097	3408	3713	0.9177	0.9047
BT-20	GSK1904529A	1.11	uM	LJP6	3	H21	72	hr	1097	3370	3696	0.9117	0.8972
BT-20	GSK1904529A	3.33	uM	LJP6	1	H20	72	hr	1097	3351	3610	0.9281	0.9150
BT-20	GSK1904529A	3.33	uM	LJP6	2	H20	72	hr	1097	3467	3713	0.9336	0.9233
BT-20	GSK1904529A	3.33	uM	LJP6	3	H20	72	hr	1097	3557	3696	0.9623	0.9566
BT-20	GSK1904529A	10	uM	LJP6	1	H19	72	hr	1097	3626	3610	1.0043	1.0050
BT-20	GSK1904529A	10	uM	LJP6	2	H19	72	hr	1097	3671	3713	0.9885	0.9869
BT-20	GSK1904529A	10	uM	LJP6	3	H19	72	hr	1097	4060	3696	1.0984	1.1100
BT-20	Linsitinib	0.04	uM	LJP5	1	O24	72	hr	1097	3134	3735	0.8390	0.8109
BT-20	Linsitinib	0.04	uM	LJP5	2	O24	72	hr	1097	3674	3877	0.9475	0.9416
BT-20	Linsitinib	0.04	uM	LJP5	3	O24	72	hr	1097	3501	3925	0.8919	0.8793
BT-20	Linsitinib	0.12	uM	LJP5	1	O23	72	hr	1097	3456	3735	0.9253	0.9140
BT-20	Linsitinib	0.12	uM	LJP5	2	O23	72	hr	1097	3866	3877	0.9970	0.9967
BT-20	Linsitinib	0.12	uM	LJP5	3	O23	72	hr	1097	3526	3925	0.8983	0.8866
BT-20	Linsitinib	0.37	uM	LJP5	1	O22	72	hr	1097	3780	3735	1.0120	1.0135
BT-20	Linsitinib	0.37	uM	LJP5	2	O22	72	hr	1097	3744	3877	0.9655	0.9618
BT-20	Linsitinib	0.37	uM	LJP5	3	O22	72	hr	1097	3544	3925	0.9028	0.8919
BT-20	Linsitinib	1.11	uM	LJP5	1	O21	72	hr	1097	3684	3735	0.9863	0.9844

|<
<<
Previous
Page 328 of 535
Next
>>
>
8176 to 8200 of 13356 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)